Linked Life Data

15708168

Source:http://linkedlifedata.com/resource/pubmed/id/15708168

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-2-14
pubmed:abstractText
Because of major advances in diagnostic and surgical methods, females with congenital heart disease (CHD) now survive into and beyond their reproductive years. Management of pregnancy in this patient population is well described, but gynecologic management such as menstruation, contraception and menopause have received scanty attention. Accordingly, the gynecologic health issues confronting these patients are described. Menstrual patterns in acyanotic females with CHD are similar to the general population, but cyanotic females have menstrual irregularities including amenorrhea, which implies anovulation and an increased risk of uterine carcinoma. Anticoagulants predispose to heavy vaginal bleeding and corpus luteum rupture. Contraceptives must be selected according to individual patient profiles. Hormone replacement therapy is warranted for relief of menopausal symptoms as in the general population and should be relatively safe because estrogen dose is low.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0167-5273
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
379-87
pubmed:dateRevised
2006-7-12
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Gynecological health of females with congenital heart disease.
pubmed:affiliation
Ahmanson UCLA Center for Adult Congenital Heart Disease, UCLA School of Nursing, Box 951702, Los Angeles, CA 90095, USA. mcanobbi@sonnet.ucla.edu
pubmed:publicationType
Journal Article, Review